Cite
MLA Citation
Sabree Burbage et al.. “Clinical surveillance and PSA outcomes among patients with non-metastatic castration resistant prostate cancer (nmCRPC) treated with a next-generation androgen receptor inhibitor (ARI) in urology clinics with or without in-office dispensing (IOD)..” Journal of clinical oncology, vol. 40, no. 28, n.d., p. 410. http://access.bl.uk/ark:/81055/vdc_100169171834.0x00002b